目的: 评估第二批国家组织药品集中采购政策（以下简称集采）在湖北省公立医疗机构的实施效果,为政策制定提供依据。方法: 选取第二批集采中选品种中的心血管系统药品为目标药物,采用描述性统计分析方法对政策实施前后药物的用药频度（DDDs）、采购金额、日均费用（DDDc）等指标进行分析。结果: 中选品种的DDDs增长87.49%,采购金额和DDDc分别下降47.00%、71.88%。中选产品的DDDs和采购金额分别增长2463.38%、310.77%,DDDc下降84.06%。结论: 第二批集采政策效果显著,有效减轻心血管疾病患者的医疗负担。

Objective: The paper is to evaluate the implementation effect of the second batch of state-organized centralized drug procurement policies in public medical institutions in Hubei Province, and to provide a basis for policy formulation. Methods: The cardiovascular system drugs in the second batch of nationally organized centralized drug procurement were selected as the target drugs. Descriptive statistical analysis method was used to analyze the drug use frequency (DDDs), purchase amount, average daily cost (DDDc) and other indicators before and after the implementation of the policy. Results: The DDDs of the selected varieties increased by 87.49%, and the purchase amount and DDDc decreased by 47.00% and 71.88% respectively. The DDDs and purchase amount of the selected products increased by 2463.38% and 310.77% respectively, and the DDDc decreased by 84.06%. Conclusion: The second batch of national centralized procurement policy has a significant effect, reducing the burden of drug costs for patients with cardiovascular disease.